Advertisement

Effects of age, gender, and lifestyle factors on plasma apolipoprotein A-IV concentrations

      Abstract

      Apolipoprotein (apo) A-IV is a protein component of triglyceride (TG)-rich lipoproteins and high density lipoproteins (HDL). Plasma apo A-IV levels were measured by immunoelectrophoresis and these values were related to other biological variables in 723 middle aged and elderly men and women (more than 90% of them were Caucasian) prior to participation in a lifestyle modification program. Apo A-IV may play an important function in regulating lipid absorption, reverse cholesterol transport, and food intake. The data are consistent with the following concepts: (1) apo A-IV levels are significantly and positively correlated with age (r=0.159, P<0.05) in all subjects, with plasma apo A-I levels in both men (r=0.194, P<0.001) and women (r=0.213, P<0.001), and with apo E (r=0.111, P<0.05) and TG levels (r=0.120, P<0.05) in men; (2) apo A-IV levels are inversely correlated with body mass index (r=0.170, P<0.05) in women; (3) female subjects on hormone replacement therapy have significantly lower plasma apo A-IV levels (by 4.1%, P<0.05) than normal controls; (4) diabetic subjects have significantly higher apo A-IV levels (by 21%, P<0.01) than normal subjects; (5) there is no significant effect of smoking, alcohol intake, and apo A-IV-1/2 genotype on apo A-IV levels. The data indicate that plasma apo A-IV levels are significantly affected by age, diabetes, and hormone replacement therapy.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Weisgraber K.H.
        • Bersot T.P.
        • Mahley R.W.
        Isolation and characterization of an apoprotein from the d less than 1.006 lipoproteins of human and canine lymph homologous with the rat A- IV apoprotein.
        Biochem. Biophys. Res. Commun. 1978; 85: 287-292
        • Green P.H.
        • Glickman R.M.
        • Riley J.W.
        • Quinet E.
        Human apolipoprotein A-IV. Intestinal origin and distribution in plasma.
        J. Clin. Invest. 1980; 65: 911-919
        • Bisgaier C.L.
        • Sachdev O.P.
        • Megna L.
        • Glickman R.M.
        Distribution of apolipoprotein A-IV in human plasma.
        J. Lipid Res. 1985; 26: 11-25
        • Miyata Y.
        • Koga S.
        • Ibayashi H.
        Alterations in plasma levels of apolipoprotein A-IV in various clinical entities.
        Gastroenterol. Jpn. 1986; 21: 479-485
        • Weinberg R.B.
        • Dantzker C.
        • Patton C.S.
        Sensitivity of serum apolipoprotein A-IV levels to changes in dietary fat content [see comments].
        Gastroenterology. 1990; 98: 17-24
        • Delamatre J.G.
        • Roheim P.S.
        The response of apolipoprotein A-IV to cholesterol feeding in rats.
        Biochim. Biophys. Acta. 1983; 751: 210-217
        • Apfelbaum T.F.
        • Davidson N.O.
        • Glickman R.M.
        Apolipoprotein A-IV synthesis in rat intestine: regulation by dietary triglyceride.
        Am. J. Physiol. 1987; 252: G662-G666
        • Hayashi H.
        • Nutting D.F.
        • Fujimoto K.
        • Cardelli J.A.
        • Black D.
        • Tso P.
        Transport of lipid and apolipoproteins A-I and A-IV in intestinal lymph of the rat.
        J. Lipid Res. 1990; 31: 1613-1625
        • Fujimoto K.
        • Cardelli J.A.
        • Tso P.
        Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation.
        Am. J. Physiol. 1992; 262: G1002-G1006
        • Kalogeris T.J.
        • Fukagawa K.
        • Tso P.
        Synthesis and lymphatic transport of intestinal apolipoprotein A-IV in response to graded doses of triglyceride.
        J. Lipid Res. 1994; 35: 1141-1151
        • Goldberg I.J.
        • Scheraldi C.A.
        • Yacoub L.K.
        • Saxena U.
        • Bisgaier C.L.
        Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.
        J. Biol. Chem. 1990; 265: 4266-4272
        • Weinberg R.B.
        • Spector M.S.
        Human apolipoprotein A-IV: displacement from the surface of triglyceride-rich particles by HDL2-associated C-apoproteins.
        J. Lipid Res. 1985; 26: 26-37
        • Chen C.H.
        • Albers J.J.
        Activation of lecithin: cholesterol acyltransferase by apolipoproteins E-2, E-3, and A-IV isolated from human plasma.
        Biochim. Biophys. Acta. 1985; 836: 279-285
        • Emmanuel F.
        • Steinmetz A.
        • Rosseneu M.
        • Brasseur R.
        • Gosselet N.
        • Attenot F.
        • Cuine S.
        • Seguret S.
        • Latta M.
        • Fruchart J.C.
        • et al.
        Identification of specific amphipathic alpha-helical sequence of human apolipoprotein A-IV involved in lecithin:cholesterol acyltransferase activation.
        J. Biol. Chem. 1994; 269: 29883-29890
        • Steinmetz A.
        • Utermann G.
        Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV.
        J. Biol. Chem. 1985; 260: 2258-2264
        • Main L.A.
        • Ohnishi T.
        • Yokoyama S.
        Activation of human plasma cholesteryl ester transfer protein by human apolipoprotein A-IV.
        Biochim. Biophys. Acta. 1996; 1300: 17-24
        • Weinberg R.B.
        • Patton C.S.
        Binding of human apolipoprotein A-IV to human hepatocellular plasma membranes.
        Biochim. Biophys. Acta. 1990; 1044: 255-261
        • Steinmetz A.
        • Barbaras R.
        • Ghalim N.
        • Clavey V.
        • Fruchart J.C.
        • Ailhaud G.
        Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells.
        J. Biol. Chem. 1990; 265: 7859-7863
        • Eckardstein A.V.
        • Huang Y.
        • Wu S.
        • Sarmadi A.S.
        • Schwarz S.
        • Steinmetz A.
        • Assmann G.
        Lipoproteins containing apolipoprotein A-IV but not apolipoprotein A-I take up and esterify cell-derived cholesterol in plasma.
        Arterioscler. Thromb. Vasc. Biol. 1995; 15: 1755-1763
        • Tso P.
        • Liu M.
        • Kalogeris T.J.
        The role of apolipoprotein A-IV in food intake regulation.
        J. Nutr. 1999; 129: 1503-1506
        • Sparks C.E.
        • Tennenberg S.D.
        • Marsh J.B.
        Catabolism of the apolipoproteins of HDL in control and nephrotic rats.
        Biochim. Biophys. Acta. 1981; 665: 8-12
        • Fujimoto K.
        • Fukagawa K.
        • Sakata T.
        • Tso P.
        Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats.
        J. Clin. Invest. 1993; 91: 1830-1833
        • Fujimoto K.
        • Machidori H.
        • Iwakiri R.
        • Yamamoto K.
        • Fujisaki J.
        • Sakata T.
        • Tso P.
        Effect of intravenous administration of apolipoprotein A-IV on patterns of feeding, drinking and ambulatory activity of rats.
        Brain Res. 1993; 608: 233-237
        • Tso P.
        • Chen Q.
        • Fujimoto K.
        • Fukagawa K.
        • Sakata T.
        Apolipoprotein A-IV: a circulating satiety signal produced by the small intestine.
        Obes. Res. 1995; 3: 689S-695S
        • Okumura T.
        • Fukagawa K.
        • Tso P.
        • Taylor I.L.
        • Pappas T.N.
        Mechanism of action of intracisternal apolipoprotein A-IV in inhibiting gastric acid secretion in rats.
        Gastroenterology. 1995; 109: 1583-1588
        • Okumura T.
        • Taylor I.L.
        • Fukagawa K.
        • Tso P.
        • Pappas T.N.
        Apolipoprotein A-IV acts centrally in the brain to reduce the severity of gastric ulceration in the rat.
        Brain Res. 1995; 673: 153-156
        • Duverger N.
        • Tremp G.
        • Caillaud J.M.
        • Emmanuel F.
        • Castro G.
        • Fruchart J.C.
        • Steinmetz A.
        • Denefle P.
        Protection against atherogenesis in mice mediated by human apolipoprotein A-IV.
        Science. 1996; 273: 966-968
        • Qin X.
        • Swertfeger D.K.
        • Zheng S.
        • Hui D.Y.
        • Tso P.
        Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation.
        Am. J. Physiol. 1998; 274: H1836-H1840
        • Barnard J.R.
        Effects of life-style modification on serum lipids.
        Arch. Intern. Med. 1991; 151: 1389-1394
        • Friedewald W.T.
        • Levy R.I.
        • Fredrickson D.S.
        Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
        Clin. Chem. 1972; 18: 499-502
        • Havel R.J.
        • Eder H.A.
        • Jh B.
        The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.
        J. Clin. Invest. 1955; 34: 1345-1353
        • Contois H.J.
        • McNamara J.R.
        • Lammi-Keefe J.C.
        • Wilson F.P.W.
        • Massov T.
        • Schaefer E.J.
        Reference intervals for plasma apolipoprotein A-I determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study.
        Clin. Chem. 1996; 42: 507-514
        • Contois H.J.
        • McNnamara R.J.
        • Lammi-Keefe J.C.
        • Wilson F.P.W.
        • Massov T.
        • Schaefer J.E.
        Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study.
        Clin. Chem. 1996; 42: 515-523
        • Tenkanen H.
        Genotyping of apolipoprotein A-IV by digestion of amplified DNA with restriction endonuclease Fnu4HI: use of a tailored primer to abolish additional recognition sites during the gene amplification.
        J. Lipid Res. 1991; 32: 545-549
        • Ehnholm C.
        • Tenkanen H.
        • de Knijff P.
        • Havekes L.
        • Rosseneu M.
        • Menzel H.J.
        • Tiret L.
        Genetic polymorphism of apolipoprotein A-IV in five different regions of Europe. Relations to plasma lipoproteins and to history of myocardial infarction: the EARS study. European Atherosclerosis Research Study.
        Atherosclerosis. 1994; 107: 229-238
        • Verges B.L.
        • Vaillant G.
        • Goux A.
        • Lagrost L.
        • Brun J.M.
        • Gambert P.
        Apolipoprotein A-IV levels and phenotype distribution in NIDDM.
        Diabetes Care. 1994; 17: 810-817
        • Verges B.L.
        • Lagrost L.
        • Vaillant G.
        • Petit J.M.
        • Cohen M.
        • Gambert P.
        • Brun J.M.
        Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM.
        Diabetes. 1997; 46: 125-132
        • Attia N.A.T.
        • Lahrichi M.
        • Balafrej A.
        • Kabbaj O.
        • Girad-Globa A.
        Response of apolipoprotein A-IV and lipoproteins to glycaemic control in young people with insulin-dependent diabetes mellitus.
        Diabet. Med. 1997; 14: 242-247
        • Bisgaier C.L.
        • Sachdev O.P.
        • Lee E.S.
        • Williams K.J.
        • Blum C.B.
        • Glickman R.M.
        Effect of lecithin:cholesterol acyltransferase on distribution of apolipoprotein A-IV among lipoproteins of human plasma.
        J. Lipid Res. 1987; 28: 693-703
        • Lagrost L.
        • Gambert P.
        • Boquillon M.
        • Lallemant C.
        Evidence for high density lipoproteins as the major apolipoprotein A-IV-containing fraction in normal human serum.
        J. Lipid Res. 1989; 30: 1525-1534
        • Verges B.
        • Rader D.
        • Schaefer J.
        • Zech L.
        • Kindt M.
        • Fairwell T.
        • Gambert P.
        • Brewer H.B.
        In vivo metabolism of apolipoprotein A-IV in severe hypertriglyceridemia: a combined radiotracer and stable isotope kinetic study.
        J. Lipid Res. 1994; 35: 2280-2291
        • Vergnes L.
        • Taniguchi T.
        • Omori K.
        • Zakin M.M.
        • Ochoa A.
        The apolipoprotein A-I/C-III/A-IV gene cluster: ApoC-III and ApoA-IV expression is regulated by two common enhancers.
        Biochim. Biophys. Acta. 1997; 1348: 299-310
        • Metzger S.
        • Levy Y.
        • Arnon R.
        • Chajek-Shaul T.
        Co-regulation of apo A-I, apo C-III and apo A-IV gene expression in human intestinal biopsies.
        Eur. J. Clin. Invest. 1996; 26: 71-75
        • Cohen J.C.
        • Wang Z.
        • Grundy S.M.
        • Stoesz M.R.
        • Guerra R.
        Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels.
        J. Clin. Invest. 1994; 94: 2377-2384
        • Boguski M.S.
        • Birkenmeier E.H.
        • Elshourbagy N.A.
        • Taylor J.M.
        • Gordon J.I.
        Evolution of the apolipoproteins. Structure of the rat apo-A-IV gene and its relationship to the human genes for apo-A-I, C-III, and E.
        J. Biol. Chem. 1986; 261: 6398-6407
        • Schaefer E.J.
        • Lamon-Fava S.
        • Cohn S.
        • Ordovas J.M.
        • Castelli W.P.
        • Wilson P.W.
        Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study.
        J. Lipid Res. 1994; 35: 779-792
        • Millar J.S.
        • Lichtenstein A.H.
        • Cruchel M.
        • Dolnikowski G.G.
        • Hachey D.L.
        • Cohn J.S.
        • Schaefer E.J.
        Impact of age on the metabolism of VLDL, IDL, and LDL apolipoprotein B100 in men.
        J. Lipid Res. 1995; 36: 1155-1167
        • Lagrost L.
        • Gambert P.
        • Meunier S.
        • Morgado P.
        • Desgres J.
        • d’Athis P.
        • Lallemant C.
        Correlation between apolipoprotein A-IV and triglyceride concentrations in human sera.
        J. Lipid Res. 1989; 30: 701-710
        • Ghiselli G.
        • Krishnan S.
        • Beigel Y.
        • Gotto Jr, A.M.
        Plasma metabolism of apolipoprotein A-IV in humans.
        J. Lipid Res. 1986; 27: 813-827
        • Utermann G.
        • Beisiegel U.
        Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification.
        Eur. J. Biochem. 1979; 99: 333-343
        • Borkan G.A.
        • Hults D.E.
        • Cardarelli J.
        • Burrows B.A.
        Comparison of ultrasound and skinfold measurements in assessment of subcutaneous and total fatness.
        Am. Phys. Anthropol. 1982; 58: 307-313
        • Martin A.D.
        • Ross W.D.
        • Drinkwater D.T.
        • Clarys J.P.
        Prediction of body fat by skinfold caliper: assumptions and cadaver evidence.
        Int. J. Obes. 1985; 9: 31-39